Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Nanotoxicology. 2010 Dec 22;5(4):592–605. doi: 10.3109/17435390.2010.541292

Figure 6. Effect of surfactants and fluconazole on monocyte and MDM viability.

Figure 6

Monocytes and MDM were loaded with 0.1 mM or 0.5 mM of individual surfactant or combination of surfactants and fluconazole manufactured using homogenization or wet milling procedures. Additional controls consisted of untreated cells and cells exposed to fluconazole alone (without surfactants, F-no NP). All surfactants and fluconazole controls had no major effect on monocytes or MDM viability. Figure shown is representative of 3 independent experiments (*P<0.01; **P<0.001). Details of surfactant composition are described in Table 1.